Propafenone Hydrochloride Capsule, Extended Release
Product Images NDC 70771-1525

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Propafenone Hydrochloride (NDC 70771-1525). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (528da2a7 3d39 42f1 B4b2 17994a7fbb5d 01)

Chemical structure diagram of Propafenone Hydrochloride showing its molecular arrangement with benzene rings, side chains, and hydrochloride component as indicated in the structure.*

FDA Label Image

Image (528da2a7 3d39 42f1 B4b2 17994a7fbb5d 02)

A Kaplan-Meier survival curve chart showing the proportion of patients without event over time (days) up to 300 days, comparing placebo and three dosing strengths of Propafenone Hydrochloride extended release (225 mg, 325 mg, and 425 mg, all given twice daily). The graph includes the number of patients at risk at various time points for each group and notes a significant difference (p < 0.001) between the treatments and placebo at week 39 (day 273).*

FDA Label Image

Label (528da2a7 3d39 42f1 B4b2 17994a7fbb5d 03)

Propafenone Hydrochloride Extended-release Capsules USP 225 mg in a package of 60 capsules. The label includes storage instructions, a child-resistant package warning, and manufacturer information (Cadila Healthcare Ltd., India). The product is prescription-only and shows the Zydus Pharmaceuticals logo.*

FDA Label Image

Label (528da2a7 3d39 42f1 B4b2 17994a7fbb5d 04)

Packaging label for Propafenone Hydrochloride Extended-release Capsules, USP 325 mg by Zydus Lifesciences Limited. The label shows a 60-capsule bottle with NDC 70771-1526-6. It includes usage instructions to keep out of children's reach, storage temperature, and a warning about the seal over the bottle opening. The label also notes the product is Rx only and child-resistant.*

FDA Label Image

Label (528da2a7 3d39 42f1 B4b2 17994a7fbb5d 05)

Label for Propafenone Hydrochloride Extended-release Capsules, USP 425 mg, containing 60 capsules by Zydus Lifesciences Limited. The label shows the NDC 70771-1527-6, states the product is for prescription use only, and includes storage instructions and child-resistant packaging information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.